The molecular targets of taurine confer anti-hyperlipidemic effects

Life Sci. 2021 Aug 1:278:119579. doi: 10.1016/j.lfs.2021.119579. Epub 2021 May 5.

Abstract

Hyperlipidemia, an independent risk factor for atherosclerosis, is regarded as a lipid metabolism disorder associated with elevated plasma triglyceride and/or cholesterol. Genetic factors and unhealthy lifestyles, such as excess caloric intake and physical inactivity, can result in hyperlipidemia. Taurine, a sulfur-containing non-essential amino acid, is abundant in marine foods and has been associated with wide-ranging beneficial physiological effects, with special reference to regulating aberrant lipid metabolism. Its anti-hyperlipidemic mechanism is complex, which is related to many enzymes in the process of fat anabolism and catabolism (e.g., HMGCR, CYP7A1, LDLR, FXR, FAS and ACC). Anti-inflammatory and antioxidant molecular targets, lipid autophagy, metabolic reprogramming and gut microbiota will also be reviewed.

Keywords: Autophagy; Cholesterol; Gut microbiota; Hyperlipidemia; Metabolic reprogramming; Taurine.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / metabolism
  • Autophagy
  • Cholesterol / metabolism
  • Cholesterol 7-alpha-Hydroxylase / metabolism
  • Diet, High-Fat
  • Fatty Acids / metabolism
  • Gastrointestinal Microbiome
  • Humans
  • Hyperlipidemias / drug therapy*
  • Inflammation
  • Lipid Metabolism
  • Lipids / blood
  • Liver / metabolism
  • Rats
  • Taurine / chemistry
  • Taurine / pharmacology*
  • Triglycerides / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Fatty Acids
  • Lipids
  • Triglycerides
  • Taurine
  • Cholesterol
  • CYP7A1 protein, human
  • CYP7A1 protein, rat
  • Cholesterol 7-alpha-Hydroxylase